Although there is no cure for CLL, the development and availability of highly effective therapies, including Bruton tyrosine kinase inhibitors (BTKis), have resulted in prolonged survival for these patients [3,5,6]. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.